Average Co-Inventor Count = 5.87
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (19 from 3,681 patents)
2. Bristol-myers Squibb Pharma Company (6 from 234 patents)
3. Dupont Pharmaceuticals Company (5 from 106 patents)
4. E.i. Dupont De Nemours and Company (1 from 16,338 patents)
31 patents:
1. 12404274 - Macrocycles as factor xia inhibitors
2. 11180490 - Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
3. 11136327 - Macrocycles as factor XIA inhibitors
4. 10487086 - Macrocycles as factor XIa inhibitors
5. 10112936 - Five-membered heterocycles useful as serine protease inhibitors
6. 9802939 - Macrocycles as factor XIa inhibitors
7. 9617224 - Five-membered heterocycles useful as serine protease inhibitors
8. 9079860 - Five-membered heterocycles useful as serine protease inhibitors
9. 8940720 - Macrocycles as factor XIa inhibitors
10. 8716492 - Five-membered heterocycles useful as serine protease inhibitors
11. 8513424 - Pyridone GPR119 G protein-coupled receptor agonists
12. 8372837 - Pyridone and pyridazone analogues as GPR119 modulators
13. 8232404 - Pyridone GPR119 G protein-coupled receptor agonists
14. 8178561 - Method for modulating GPR119 G protein-coupled receptor and selected compounds
15. 8101778 - Five-membered heterocycles useful as serine protease inhibitors